Major innovations support modern clinical research designs and decentralized models for conducting studies
PHILADELPHIA† June 29, 2022 /PRNewswire/ — Signant Health, the leader in generating evidence for modern clinical trials, today announced the latest advancements in its electronic Clinical Outcomes Assessment (eCOA) software, Signant SmartSignals eCOA. The improvements address the needs of trial sponsors and CROs seeking eCOA solutions that are highly configurable, faster to deploy, and run on any type of device from a single study build.
SmartSignals eCOA uses a drag-and-drop design tool that delivers consumer-grade user interfaces that automatically adapt to any device, speeding up the study design process by 40% – 60%. It also streamlines the verification process, allowing research teams to easily visualize their eCOA study design and validate alignment with a protocol’s event schedule or activity tables.
The software has a built-in, comprehensive eCOA library that makes pre-validated, reusable scales readily available on any device, and includes simplified language version management.
In addition to these back-end optimizations that benefit study teams, SmartSignals eCOA provides trial participants with clean, modern, and straightforward interfaces to simplify the capture of patient-reported outcome data. Built-in engagement features include easy access to exam and treatment information, up-to-date visit schedules, secure video visits, and exam notifications that guide patients through the exam.
“These latest capabilities of our eCOA software represent more than a year of thoughtful development. SmartSignals eCOA has been an industry standard bearer for over two decades, supporting more than 25% of all new drug approvals in the US by 2021 and Europe,” said Sanjiv Waghmare, Signant’s Chief Product Officer. “Our new eCOA design tools and utilities allow us to maintain the same standards of data quality and integrity that we are known for, while speeding up the study build process and reducing the burden on study teams. Importantly, our customers, locations and patients supervised, tested, and approved these design innovations.”
Signant’s updated eCOA design tools, utilities and features are available as a standalone solution or bundled with other key digital trial options such as eConsent and telemedicine, supported by the company’s rich tradition of clinical science and global delivery.
About Signant Health
Signant Health is the evidence generation company. We are focused on using software, deep therapeutic and scientific knowledge, and operational expertise to capture, collect and reveal consistent quality evidence for clinical trials in traditional, virtual and hybrid research models. For more than 20 years, more than 400 sponsors and CROs of all sizes – including all Top 20 pharmaceutical companies – have trusted Signant solutions for remote and site-based eCOA, eConsent, RTSM, supply chain management and data quality analytics. Learn more at www.signanthealth.com.
SOURCE Signant Health